Xiaoyang Lu

4.0k total citations
67 papers, 1.7k citations indexed

About

Xiaoyang Lu is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Xiaoyang Lu has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Xiaoyang Lu's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), COVID-19 Clinical Research Studies (8 papers) and Advanced Drug Delivery Systems (7 papers). Xiaoyang Lu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), COVID-19 Clinical Research Studies (8 papers) and Advanced Drug Delivery Systems (7 papers). Xiaoyang Lu collaborates with scholars based in China, United States and Tunisia. Xiaoyang Lu's co-authors include Yuefeng Rao, Lin Liu, Jianqing Gao, Wendong Yao, Saiping Jiang, Dongsheng Hong, Ping Yang, Yan Lou, Yonghong Xiao and Yunbo Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Xiaoyang Lu

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyang Lu China 23 291 240 233 228 207 67 1.7k
Fadilah Sfouq Aleanizy Saudi Arabia 23 389 1.3× 235 1.0× 185 0.8× 93 0.4× 170 0.8× 82 1.7k
Hamid A. Merchant United Kingdom 26 298 1.0× 211 0.9× 687 2.9× 132 0.6× 234 1.1× 66 2.5k
Teresa Dalla Costa Brazil 27 564 1.9× 185 0.8× 402 1.7× 228 1.0× 138 0.7× 149 2.4k
Gang Cheng China 25 534 1.8× 319 1.3× 723 3.1× 164 0.7× 304 1.5× 90 2.4k
Goutam Ghosh India 22 322 1.1× 233 1.0× 337 1.4× 79 0.3× 162 0.8× 134 1.9k
Chi Tim Hung China 26 481 1.7× 438 1.8× 337 1.4× 76 0.3× 277 1.3× 116 2.5k
Fulwah Yahya Alqahtani Saudi Arabia 21 354 1.2× 217 0.9× 131 0.6× 76 0.3× 153 0.7× 69 1.5k
Amal G. Al‐Bakri Jordan 25 526 1.8× 92 0.4× 107 0.5× 160 0.7× 139 0.7× 48 1.7k
Shaimaa M. Badr-Eldin Saudi Arabia 26 489 1.7× 305 1.3× 1.0k 4.3× 124 0.5× 176 0.9× 75 2.3k
José‐Esteban Peris Spain 31 701 2.4× 198 0.8× 564 2.4× 120 0.5× 120 0.6× 95 2.9k

Countries citing papers authored by Xiaoyang Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyang Lu more than expected).

Fields of papers citing papers by Xiaoyang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyang Lu. The network helps show where Xiaoyang Lu may publish in the future.

Co-authorship network of co-authors of Xiaoyang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyang Lu. A scholar is included among the top collaborators of Xiaoyang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyang Lu. Xiaoyang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Limin, Fan Li, Yujun Zhou, et al.. (2025). Identification of CD38 high Monocyte as a Candidate Diagnostic Biomarker and Therapeutic Target for Sepsis. Advanced Science. 12(23). e2500457–e2500457. 5 indexed citations
2.
Fu, Lijun, et al.. (2024). Surface Engineering on Bacteria for Tumor Immunotherapy: Strategies and Perspectives. Advanced Functional Materials. 34(42). 19 indexed citations
3.
Yang, Ping, Qingyu Li, Xumei Li, et al.. (2024). A multicenter clinical study on the incidence and influencing factors of cephalosporin-induced anaphylaxis. Journal of Zhejiang University (Medical Sciences). 53(5). 615–622. 1 indexed citations
4.
Chen, Na, Xiaojuan Wang, Yinyan Li, et al.. (2023). Population Pharmacokinetics of Isavuconazole in Adult: A Systematic Review. Infection and Drug Resistance. Volume 16. 7559–7568. 1 indexed citations
5.
Wang, Xiaojuan, et al.. (2021). Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats. Journal of Zhejiang University SCIENCE B. 22(7). 599–602. 2 indexed citations
6.
Pan, Zongfu, et al.. (2021). Regulatory Master Genes Identification and Drug Repositioning by Integrative mRNA-miRNA Network Analysis for Acute Type A Aortic Dissection. Frontiers in Pharmacology. 11. 575765–575765. 12 indexed citations
7.
Liu, Lin, Wendong Yao, Xiaowei Xie, Jian-Qing Gao, & Xiaoyang Lu. (2021). pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia. Journal of Nanobiotechnology. 19(1). 235–235. 22 indexed citations
8.
L, Li, et al.. (2020). Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Zhu, Lin, Donald L. Patrick, Ying Li, et al.. (2020). Work–health–personal life conflicts in naive patients with chronic hepatitis B receiving initial treatment in China: a qualitative study. BMJ Open. 10(9). e035688–e035688. 2 indexed citations
10.
Li, Lu, Xin Li, Jia Li, et al.. (2020). Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. Frontiers in Pharmacology. 11. 786–786. 73 indexed citations
11.
Jiang, Saiping, Rongrong Wang, Lu Li, et al.. (2020). Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in Medicine. 7. 347–347. 26 indexed citations
12.
Li, Lu, et al.. (2020). <p>Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients</p>. Drug Design Development and Therapy. Volume 14. 3001–3013. 22 indexed citations
13.
He, Yang, Jianhua Zhang, Guofang Shen, et al.. (2019). Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: a systematic review and meta-analysis. BMC Pharmacology and Toxicology. 20(1). 62–62. 9 indexed citations
14.
Yang, Ping, Yunbo Chen, Saiping Jiang, et al.. (2018). Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrobial Resistance and Infection Control. 7(1). 137–137. 88 indexed citations
15.
Liu, Lin, Hui Yang, Yan Lou, et al.. (2018). Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. International Journal of Pharmaceutics. 557. 170–177. 30 indexed citations
16.
Yang, Ping, Saiping Jiang, & Xiaoyang Lu. (2017). Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital. Therapeutics and Clinical Risk Management. Volume 13. 469–476. 9 indexed citations
17.
Chen, Jian, Xiaoyang Lu, Weijia Wang, et al.. (2014). Impact of a Clinical Pharmacist-Led Guidance Team on Cancer Pain Therapy in China: A Prospective Multicenter Cohort Study. Journal of Pain and Symptom Management. 48(4). 500–509. 39 indexed citations
18.
Jiang, Saiping, Zhengyi Zhu, Xiaoliang Wu, et al.. (2014). Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study. Therapeutics and Clinical Risk Management. 10. 405–405. 27 indexed citations
19.
Jiang, Saiping, Yanyan Xu, Xingguo Zhang, et al.. (2014). Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment. European Journal of Internal Medicine. 25(10). 930–935. 15 indexed citations
20.
Jiang, Saiping, et al.. (2013). Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit. Scandinavian Journal of Infectious Diseases. 45(12). 891–899. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fadilah Sfouq Aleanizy Breakdown of academic impact, for papers by Hamid A. Merchant Breakdown of academic impact, for papers by Teresa Dalla Costa Breakdown of academic impact, for papers by Gang Cheng Breakdown of academic impact, for papers by Goutam Ghosh Breakdown of academic impact, for papers by Chi Tim Hung Breakdown of academic impact, for papers by Fulwah Yahya Alqahtani Breakdown of academic impact, for papers by Amal G. Al‐Bakri Breakdown of academic impact, for papers by Shaimaa M. Badr-Eldin Breakdown of academic impact, for papers by José‐Esteban Peris
Rankless by CCL
2026